Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309562521> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4309562521 abstract "Abstract Background In Ireland between 2008 and 2022, intramammary antimicrobial (AM) products could be prescribed by a veterinary practitioner under what was known as Schedule 8 (or remote) prescribing. Under this prescribing route, an annual herd visit was not required when criteria were met as outlined in Animal Remedies Regulation 2007 to 2017 (statutory instruments No. 786/2007 and 558/2017). Under this prescribing route, the responsibilities of the milk purchaser, the farmer and the veterinary practitioner were each outlined, and a written mastitis control programme (MCP) was required. Milk purchasers implemented MCPs on participating farms (so-called MCP herds) with support from veterinary practitioner(s) who undertook Schedule 8 prescribing of intramammary AM tubes. This study seeks a clearer understanding of the role of milk purchasers in the prescribing and sale of intramammary AM products in Ireland during 2019 and 2020, whilst this Regulation was in force. Specifically, the study sought insights into the role of milk purchasers in the prescribing and sale of intramammary AM products in the Irish dairy industry during 2019 and 2020, using anonymised and highly aggregated milk purchaser data. The study also provided insights into milk quality among supplying herds during this period. Methods For this study, we had access to anonymised, highly aggregated data from all milk purchasers that operated a MCP on at least some of their supplying herds during 2019 or 2020. Data collection was undertaken by the Department of Agriculture, Food and Marine. Data analysis was primarily descriptive. Results Data were available on 11 milk purchasers (64.7% of all) and 13,251 supplying herds. Of these, 52% were MCP herds. The quality of milk from supplying herds varied significantly by month, year and milk purchaser. During 2019 and 2020, there was a single Schedule 8 prescriber (a private veterinary practitioner prescribing intramammary AMs as part of a MCP), on average, for 549.3 herds. The sale of intramammary AM products through milk purchasers represented 15.2% and 26.9% of national sales in in-lactation and dry cow tubes, respectively. There was an overall 2% increase in sales through milk purchasers between 2019 and 2020. Few European Medicines Agency (EMA) category B (‘ Restrict ’) intramammary AM products were sold by milk purchasers. For both in-lactation and dry cow tubes, there was a statistically significant association between EMA classification and route of sale (through milk purchasers or otherwise). Conclusions The study findings provide important insights into mastitis control and intramammary AM stewardship in the Irish dairy industry. Significant differences between milk purchasers were observed in the quality of milk, as measured through somatic cell count (SCC) values, from supplying herds. This warrants further research. In the context of intramammary AM prescribing, veterinary oversight under the Animal Remedies Regulation 2007 to 2017 was very limited during 2019 and 2020. There were also significant associations between EMA classification and route of sale during 2019 and 2020, reinforcing the need for Irish veterinary practitioners to move away from EMA category B intramammary AMs. Higher quality data are needed to address important industry questions. Specifically it is recommended that national bulk tank SCC data are made available for public good research. Past experiences with Schedule 8 prescribing (no longer permitted from 28 January 2022) may influence current efforts towards improved intramammary AM stewardship." @default.
- W4309562521 created "2022-11-28" @default.
- W4309562521 creator A5011421906 @default.
- W4309562521 creator A5056793891 @default.
- W4309562521 creator A5059868887 @default.
- W4309562521 date "2022-11-19" @default.
- W4309562521 modified "2023-10-13" @default.
- W4309562521 title "Prescribing and sales of intramammary antimicrobials in Ireland in 2019 and 2020: the role of milk purchasers" @default.
- W4309562521 cites W2018419656 @default.
- W4309562521 cites W2058399769 @default.
- W4309562521 cites W2060493228 @default.
- W4309562521 cites W2080925568 @default.
- W4309562521 cites W2100616761 @default.
- W4309562521 cites W2153174525 @default.
- W4309562521 cites W2589937775 @default.
- W4309562521 cites W2627082753 @default.
- W4309562521 cites W2789541330 @default.
- W4309562521 cites W2793930605 @default.
- W4309562521 cites W3009883428 @default.
- W4309562521 cites W3049741525 @default.
- W4309562521 cites W3119170307 @default.
- W4309562521 cites W3119935863 @default.
- W4309562521 cites W3130057170 @default.
- W4309562521 cites W3176510591 @default.
- W4309562521 cites W4210533691 @default.
- W4309562521 cites W4221025834 @default.
- W4309562521 cites W4223590503 @default.
- W4309562521 doi "https://doi.org/10.1186/s13620-022-00227-4" @default.
- W4309562521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36403021" @default.
- W4309562521 hasPublicationYear "2022" @default.
- W4309562521 type Work @default.
- W4309562521 citedByCount "0" @default.
- W4309562521 crossrefType "journal-article" @default.
- W4309562521 hasAuthorship W4309562521A5011421906 @default.
- W4309562521 hasAuthorship W4309562521A5056793891 @default.
- W4309562521 hasAuthorship W4309562521A5059868887 @default.
- W4309562521 hasBestOaLocation W43095625211 @default.
- W4309562521 hasConcept C118518473 @default.
- W4309562521 hasConcept C142724271 @default.
- W4309562521 hasConcept C144133560 @default.
- W4309562521 hasConcept C166957645 @default.
- W4309562521 hasConcept C194775826 @default.
- W4309562521 hasConcept C205649164 @default.
- W4309562521 hasConcept C2776040555 @default.
- W4309562521 hasConcept C2776344049 @default.
- W4309562521 hasConcept C42972112 @default.
- W4309562521 hasConcept C501593827 @default.
- W4309562521 hasConcept C71924100 @default.
- W4309562521 hasConcept C86803240 @default.
- W4309562521 hasConcept C89423630 @default.
- W4309562521 hasConcept C94665300 @default.
- W4309562521 hasConceptScore W4309562521C118518473 @default.
- W4309562521 hasConceptScore W4309562521C142724271 @default.
- W4309562521 hasConceptScore W4309562521C144133560 @default.
- W4309562521 hasConceptScore W4309562521C166957645 @default.
- W4309562521 hasConceptScore W4309562521C194775826 @default.
- W4309562521 hasConceptScore W4309562521C205649164 @default.
- W4309562521 hasConceptScore W4309562521C2776040555 @default.
- W4309562521 hasConceptScore W4309562521C2776344049 @default.
- W4309562521 hasConceptScore W4309562521C42972112 @default.
- W4309562521 hasConceptScore W4309562521C501593827 @default.
- W4309562521 hasConceptScore W4309562521C71924100 @default.
- W4309562521 hasConceptScore W4309562521C86803240 @default.
- W4309562521 hasConceptScore W4309562521C89423630 @default.
- W4309562521 hasConceptScore W4309562521C94665300 @default.
- W4309562521 hasIssue "1" @default.
- W4309562521 hasLocation W43095625211 @default.
- W4309562521 hasLocation W43095625212 @default.
- W4309562521 hasLocation W43095625213 @default.
- W4309562521 hasLocation W43095625214 @default.
- W4309562521 hasOpenAccess W4309562521 @default.
- W4309562521 hasPrimaryLocation W43095625211 @default.
- W4309562521 hasRelatedWork W1532733092 @default.
- W4309562521 hasRelatedWork W1951134622 @default.
- W4309562521 hasRelatedWork W2081153754 @default.
- W4309562521 hasRelatedWork W2098412127 @default.
- W4309562521 hasRelatedWork W2294600189 @default.
- W4309562521 hasRelatedWork W2409366625 @default.
- W4309562521 hasRelatedWork W2418013502 @default.
- W4309562521 hasRelatedWork W2460257556 @default.
- W4309562521 hasRelatedWork W4290430703 @default.
- W4309562521 hasRelatedWork W4312226574 @default.
- W4309562521 hasVolume "75" @default.
- W4309562521 isParatext "false" @default.
- W4309562521 isRetracted "false" @default.
- W4309562521 workType "article" @default.